Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 17 04 2018
accepted: 31 01 2019
entrez: 3 3 2019
pubmed: 3 3 2019
medline: 18 9 2020
Statut: epublish

Résumé

Variants of unknown/uncertain significance (VUS) pose a huge dilemma in current genetic variation screening methods and genetic counselling. Driven by methods of next generation sequencing (NGS) such as whole exome sequencing (WES), a plethora of VUS are being detected in research laboratories as well as in the health sector. Motivated by this overabundance of VUS, we propose a novel computational methodology, termed VariantClassifier (VarClass), which utilizes gene-association networks and polygenic risk prediction models to shed light into this grey area of genetic variation in association with disease. VarClass has been evaluated using numerous validation steps and proves to be very successful in assigning significance to VUS in association with specific diseases of interest. Notably, using VUS that are deemed significant by VarClass, we improved risk prediction accuracy in four large case-studies involving disease-control cohorts from GWAS as well as WES, when compared to traditional odds ratio analysis. Biological interpretation of selected high scoring VUS revealed interesting biological themes relevant to the diseases under investigation. VarClass is available as a standalone tool for large-scale data analyses, as well as a web-server with additional functionalities through a user-friendly graphical interface.

Identifiants

pubmed: 30824863
doi: 10.1038/s41598-019-39796-w
pii: 10.1038/s41598-019-39796-w
pmc: PMC6397233
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3266

Références

Lab Med. 2015 Fall;46(4):285-9
pubmed: 26489672
J Natl Cancer Inst. 2015 Nov 19;108(2):
pubmed: 26586665
Methods Mol Biol. 2009;577:67-79
pubmed: 19718509
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Med J Islam Repub Iran. 2016 May 15;30:369
pubmed: 27493913
Nat Genet. 2012 Nov;44(11):1191-8
pubmed: 23001124
Am J Hum Genet. 2006 Sep;79(3):500-13
pubmed: 16909388
Genome Med. 2014 Dec 19;6(12):121
pubmed: 25593598
PLoS Comput Biol. 2013;9(7):e1003153
pubmed: 23874191
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Biomed Res Int. 2014;2014:543673
pubmed: 25525598
Sci Rep. 2015 Jan 22;5:7953
pubmed: 25608792
EMBO Mol Med. 2013 Oct;5(10):1523-36
pubmed: 24092663
Arch Intern Med. 2003 Mar 24;163(6):705-11
pubmed: 12639204
Trends Genet. 2011 May;27(5):196-205
pubmed: 21497936
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Stat Med. 2012 Jan 30;31(2):101-13
pubmed: 22147389
Biopreserv Biobank. 2015 Oct;13(5):307-8
pubmed: 26484569
Genet Med. 2016 Nov;18(11):1151-1157
pubmed: 27031084
Ann Oncol. 2013 Nov;24 Suppl 8:viii69-viii74
pubmed: 24131974
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
EMBO J. 2012 Jun 26;31(14):3038-62
pubmed: 22735187
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W444-9
pubmed: 21576219
J Neural Transm (Vienna). 2015 Jan;122(1):145-53
pubmed: 25432432
Nucleic Acids Res. 2017 Jan 4;45(D1):D840-D845
pubmed: 27899611
Age (Dordr). 2009 Sep;31(3):211-20
pubmed: 19714491
Nat Rev Genet. 2015 Dec;16(12):689-701
pubmed: 26503796
Eur J Epidemiol. 2011 Apr;26(4):261-4
pubmed: 21431839
J Natl Cancer Inst. 2016 Aug 31;108(12):
pubmed: 27582380
J Intellect Disabil Res. 2009 Jan;53(1):85-90
pubmed: 18705633
Nucleus. 2014;5(6):508-19
pubmed: 25484187
J Intellect Disabil Res. 2007 Mar;51(Pt 3):228-31
pubmed: 17300418
Biochim Biophys Acta. 2010 Jan;1802(1):29-44
pubmed: 19733240
Mov Disord. 2016 Jan;31(1):79-85
pubmed: 26268663
Hum Mol Genet. 2002 Oct 1;11(20):2463-8
pubmed: 12351582
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20
pubmed: 20576703
Asian J Androl. 2016 Jul-Aug;18(4):520-4
pubmed: 27080480
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Cancer Biol Ther. 2008 Jan;7(1):135-44
pubmed: 18059179
J Invest Dermatol. 2016 Mar;136(3):690-695
pubmed: 27015455
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Acta Neuropathol. 2012 Feb;123(2):173-88
pubmed: 22057787
Int J Cancer. 2006 Apr 1;118(7):1769-72
pubmed: 16231334
Am J Hum Genet. 2007 Nov;81(5):939-63
pubmed: 17924337
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
BMC Genomics. 2017 Aug 3;18(1):575
pubmed: 28774272
Bioinformatics. 2003 Feb 12;19(3):376-82
pubmed: 12584123
Lancet Neurol. 2015 Oct;14(10):1002-9
pubmed: 26271532
Genome Med. 2017 Nov 13;9(1):96
pubmed: 29132412
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Proteomics. 2011 Mar;11(5):865-82
pubmed: 21280218
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Dev Med Child Neurol. 1982 Dec;24(6):817-29
pubmed: 6218002
Fluids Barriers CNS. 2012 Nov 09;9(1):23
pubmed: 23140302
Cancer Res Treat. 2017 Apr;49(2):408-415
pubmed: 27488874
Lung Cancer Int. 2016;2016:6787648
pubmed: 27752368
Mol Syst Biol. 2007;3:83
pubmed: 17299419
J Pers Med. 2015 Feb 05;5(1):22-9
pubmed: 25809799
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Am J Hum Genet. 1995 Sep;57(3):609-18
pubmed: 7668289

Auteurs

Anastasis Oulas (A)

The Cyprus Institute of Neurology & Genetics, Bioinformatics Group, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus. anastasioso@cing.ac.cy.
The Cyprus School of Molecular Medicine, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus. anastasioso@cing.ac.cy.

George Minadakis (G)

The Cyprus Institute of Neurology & Genetics, Bioinformatics Group, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus.
The Cyprus School of Molecular Medicine, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus.

Margarita Zachariou (M)

The Cyprus Institute of Neurology & Genetics, Bioinformatics Group, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus.
The Cyprus School of Molecular Medicine, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus.

George M Spyrou (GM)

The Cyprus Institute of Neurology & Genetics, Bioinformatics Group, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus.
The Cyprus School of Molecular Medicine, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH